VALLEY FORGE, Pa.--(BUSINESS WIRE)--Nov. 2, 2001--PharMerica,
Inc., a wholly-owned subsidiary of AmerisourceBergen Corporation
(NYSE:ABC), today announced that no Notes were tendered in response to
its offer to purchase its 8.375% Senior Subordinated Notes due in
2008.
The offer, which commenced on September 28, 2001 and expired on
October 29, 2001, was required under the applicable indenture as a
result of the merger of AmeriSource Health Corporation and Bergen
Brunswig Corporation on August 29, 2001. A total of $123.5 million
principal amount of these Notes remain outstanding.
About AmerisourceBergen Corporation
AmerisourceBergen is the largest pharmaceutical services company
in the United States dedicated solely to the pharmaceutical supply
chain. It is the leading distributor of pharmaceutical products and
services to the hospital systems/acute care market, alternative care
facilities, independent community pharmacies, and regional drugstore
chains.
AmerisourceBergen is also a leader in the institutional pharmacy
marketplace. With approximately $36 billion in annualized operating
revenues, AmerisourceBergen is headquartered in Valley Forge, PA, and
employs more than 13,000 people serving over 25,000 customers.
Forward-Looking Statements
This press release may contain certain "forward-looking
statements" within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934. These
statements are based on management's current expectations and are
subject to uncertainty and changes in circumstances. Actual results
may vary materially from the expectations contained in the
forward-looking statements. The forward-looking statements herein
include statements addressing future financial and operating results
of AmerisourceBergen and the benefits and other aspects of the merger.
The following factors, among others, could cause actual results to
differ materially from those described in the forward-looking
statements: the risk that the businesses of AmeriSource and Bergen
Brunswig will not be integrated successfully; failure to obtain and
retain expected synergies; and other economic, business, competitive
and/or regulatory factors affecting the business of AmerisourceBergen
generally.
More detailed information about these factors is set forth in
AmeriSource's and Bergen Brunswig's filings with the Securities and
Exchange Commission, including each of their Annual Reports on Form
10-K for fiscal 2000, their most recent quarterly reports on Form
10-Q, and their joint proxy statement-prospectus dated August 1, 2001.
AmerisourceBergen, AmeriSource and Bergen Brunswig are under no
obligation to (and expressly disclaim any such obligation to) update
or alter their forward-looking statements whether as a result of new
information, future events or otherwise.
CONTACT: |
AmerisourceBergen Corporation, Valley Forge |
---|
|
Michael N. Kilpatric, 610/727-7118 |
---|
|
mkilpatric@amerisource.com |
---|
|
---|
|
---|